CONTACT US   |  (864) 397-5101

Watch And Listen: Life Sciences Industry Impact with Bob Coughlin, JLL Director and former MassBio CEO

Recorded at SCBIO 2024, Taking the Pulse Podcast welcomes life sciences industry titan Bob Coughlin. Bob is currently a Managing Director at JLL, the former CEO of MassBio, and a patient advocate as the father of a child with cystic fibrosis. We have an insightful conversation about the positive and widespread impact of life sciences innovations, commercial space and real estate trends for life sciences companies, and the growth of the industry in South Carolina. Tune in now for an insightful episode!

Taking the Pulse: A Health Care and Life Sciences Podcast, a weekly series that takes a current look at one of America’s largest industry sectors. Listen to more episodes of the podcast at

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.